What is ATYR's relative strength rating?

ATYR ranks at the 78th percentile over 1 month, 9th percentile over 3 months, 24th percentile over 6 months, 5th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is ATYR in?

ATYR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is ATYR in a leading sector?

Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is ATYR?

ATYR currently shows a 20-day average daily range (ADR%) of 9.9%, a 90-day beta versus the S&P 500 of 2.58. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does ATYR have a seasonal pattern?

TickerStance computes ATYR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ATYR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did ATYR last report earnings?

ATYR most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-15. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

aTyr Pharma, Inc. Common Stock (ATYR) · RS 24

Free

Loading ticker…

Dossier · Pro

aTyr Pharma, Inc. Common Stock · Healthcare · Pharmaceutical Products

$0.53▼-5.75%

Neutral · stance 47

TODAY'S READ · AS OF 2026-06-26

As of 2026-06-26, aTyr Pharma, Inc. Common Stock (ATYR) has a 3-month relative strength percentile of 9 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.9%, relative volume 4.83×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

ATYRaTyr Pharma, Inc. Common Stock

$0.53-0.03 ▼ -5.75%

RS 9·−93% from high·−15% vs 50D

RANGE

ATYR daily OHLC, last 60 sessions
Date	Open	High	Low	Close	Volume
2026-04-01	0.80	0.86	0.79	0.85	1801784.584645
2026-04-02	0.84	0.87	0.81	0.85	704056.438229
2026-04-06	0.84	0.87	0.82	0.82	729175.185079
2026-04-07	0.81	0.82	0.76	0.80	919553.64207
2026-04-08	0.83	0.84	0.79	0.80	686108.283577
2026-04-09	0.79	0.80	0.75	0.75	1205765.591201
2026-04-10	0.77	0.85	0.75	0.83	980599.681018
2026-04-13	0.83	0.85	0.80	0.81	792285.471474
2026-04-14	0.82	0.88	0.82	0.84	654029.996711
2026-04-15	0.85	0.87	0.83	0.84	1058544.569608
2026-04-16	0.86	0.87	0.82	0.83	613391.624295
2026-04-17	0.85	0.87	0.83	0.85	700920.849317
2026-04-20	0.86	0.87	0.84	0.85	850371.094855
2026-04-21	0.84	0.86	0.82	0.82	584458.480527
2026-04-22	0.83	0.86	0.83	0.84	751307.424913
2026-04-23	0.85	0.85	0.79	0.79	836666.438098
2026-04-24	0.78	0.82	0.78	0.79	910096.893067
2026-04-27	0.79	0.84	0.77	0.79	1152070.389652
2026-04-28	0.79	0.81	0.78	0.79	581510.729848
2026-04-29	0.80	0.80	0.75	0.77	999793.167951
2026-04-30	0.76	0.81	0.76	0.81	752286.884039
2026-05-01	0.81	0.88	0.81	0.83	1569052.56478
2026-05-04	0.85	0.86	0.82	0.84	756711.321508
2026-05-05	0.86	0.86	0.82	0.84	749759.297122
2026-05-06	0.85	1.05	0.83	1.04	4157395.730412
2026-05-07	1.03	1.03	0.90	0.92	1256169.423479
2026-05-08	0.94	0.96	0.90	0.95	901323.306705
2026-05-11	0.95	0.99	0.93	0.95	951512.600743
2026-05-12	0.80	0.80	0.51	0.53	12098666.400648
2026-05-13	0.54	0.54	0.40	0.40	13267693.254232
2026-05-14	0.42	0.58	0.41	0.56	13817032.359683
2026-05-15	0.58	0.58	0.49	0.50	3538060.733365
2026-05-18	0.51	0.54	0.46	0.52	5394201.258372
2026-05-19	0.50	0.53	0.48	0.48	2876861.516512
2026-05-20	0.50	0.55	0.50	0.53	3412927.193023
2026-05-21	0.52	0.55	0.51	0.53	2765080.408447
2026-05-22	0.53	0.54	0.49	0.49	3184661.213399
2026-05-26	0.49	0.50	0.48	0.48	2282223.762369
2026-05-27	0.50	0.50	0.47	0.48	2511931.278543
2026-05-28	0.48	0.50	0.46	0.49	9782668.730202
2026-05-29	0.54	0.57	0.52	0.54	5429032.081589
2026-06-01	0.53	0.59	0.51	0.55	4420231.518376
2026-06-02	0.56	0.56	0.52	0.52	1935235.742927
2026-06-03	0.51	0.53	0.50	0.50	1723538.455548
2026-06-04	0.51	0.54	0.51	0.51	1472391.55183
2026-06-05	0.52	0.52	0.46	0.47	2784308.477235
2026-06-08	0.47	0.47	0.44	0.44	1777827.360155
2026-06-09	0.46	0.47	0.44	0.46	1776974.363452
2026-06-10	0.46	0.48	0.45	0.47	968944.887471
2026-06-11	0.47	0.48	0.44	0.48	1230477.418402
2026-06-12	0.47	0.47	0.44	0.44	1428264.729932
2026-06-15	0.47	0.48	0.44	0.44	1600872.522767
2026-06-16	0.44	0.46	0.44	0.45	643139.341684
2026-06-17	0.44	0.50	0.44	0.46	1582783.72843
2026-06-18	0.48	0.49	0.45	0.45	1532857.895188
2026-06-22	0.45	0.49	0.45	0.47	1875492.972602
2026-06-23	0.46	0.56	0.46	0.54	2894408.732142
2026-06-24	0.52	0.59	0.51	0.56	3639339.433756
2026-06-25	0.58	0.59	0.54	0.56	1787686.581331
2026-06-26	0.55	0.58	0.52	0.53	12153226.826239

2026-06-26·O 0.55H 0.58L 0.52C 0.53-0.03 ▼·VOL 12.2M

SRC · EOD·126 SESSIONS · 1D

§ Seasonality

10y · since 2024

Best monthOct on averageavg +48.66% · 100% win · n 2

Worst monthSep on averageavg -46.24% · 0% win · n 2

ATYR monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	ATYR Jan avg: 9.68% median: 9.68% win: 100% σ: 4.31% n: 2 2024-06-06 → 2026-05-29	ATYR Feb avg: 5.59% median: 5.59% win: 100% σ: 4.43% n: 2 2024-06-06 → 2026-05-29	ATYR Mar avg: -21.19% median: -21.19% win: 0% σ: 3.47% n: 2 2024-06-06 → 2026-05-29	ATYR Apr avg: 9.21% median: 9.21% win: 100% σ: 8.05% n: 2 2024-06-06 → 2026-05-29	ATYR May avg: -1.99% median: -1.99% win: 50% σ: 43.58% n: 2 2024-06-06 → 2026-05-29	ATYR Jun avg: -0.43% median: -0.43% win: 50% σ: 19.59% n: 2 2024-06-06 → 2026-05-29 (current)	ATYR Jul avg: 10.01% median: 10.01% win: 50% σ: 23.92% n: 2 2024-06-06 → 2026-05-29	ATYR Aug avg: 4.21% median: 4.21% win: 50% σ: 13.82% n: 2 2024-06-06 → 2026-05-29	ATYR Sep avg: -46.24% median: -46.24% win: 0% σ: 57.07% n: 2 2024-06-06 → 2026-05-29	ATYR Oct avg: 48.66% median: 48.66% win: 100% σ: 40.47% n: 2 2024-06-06 → 2026-05-29	ATYR Nov avg: 1.63% median: 1.63% win: 50% σ: 16.27% n: 2 2024-06-06 → 2026-05-29	ATYR Dec avg: 1.44% median: 1.44% win: 100% σ: 1.57% n: 2 2024-06-06 → 2026-05-29

Fundamentals · ATYR

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q1 · period end 2026-03-31

—

Fundamentals Growth Rank

How does growth rank vs. the universe?

Insufficient data for factor compute

View fundamental leadership map

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss narrowing

−$0.23—

24 Q2

−$0.23—

24 Q3

−$0.17—

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

ETF OWNERS

ETFs holding ATYR

ATYR is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional. Top 3 carry $5M.

ETFs holding: 5
Total value: $5M
Top 3 concentration: 87.6%
Max weight: IWO · 0.00%

Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.

ETFs holding ATYR ranked by value
ETF	Weight	Value
VTIVanguard Total Stock Market ETF	0.00%	$2M
IWMiShares Russell 2000 ETF	0.00%	$2M
VXFVanguard Extended Market ETF	0.00%	$785K
IWOiShares Russell 2000 Growth ETF	0.00%	$532K
ITOTiShares Core S&P Total U.S. Stock Market ETF	0.00%	$111K

FAQ

Frequently asked questions

What is ATYR's relative strength rating?: ATYR ranks at the 78th percentile over 1 month, 9th percentile over 3 months, 24th percentile over 6 months, 5th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is ATYR in?: ATYR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is ATYR in a leading sector?: Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is ATYR?: ATYR currently shows a 20-day average daily range (ADR%) of 9.9%, a 90-day beta versus the S&P 500 of 2.58. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does ATYR have a seasonal pattern?: TickerStance computes ATYR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ATYR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did ATYR last report earnings?: ATYR most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-15. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

§ Seasonality

Does the business back the chart?

Are losses narrowing?

Receipts behind the read

Is it leading?

Who's accumulating?

ATYR is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Pattern read

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

ETFs holding ATYR

Frequently asked questions

§ Seasonality

aTyr Pharma, Inc. Common Stock (ATYR) — Stance & relative strength

Does the business back the chart?

Are losses narrowing?

Receipts behind the read

Is it leading?

Who's accumulating?

ATYR is not confirmed as a leader.

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

How much does it move?

Pattern read

Sector context

Who else is leading?

Healthcare

Same industry, closest relative strength

Market backdrop

Is the crowd watching?

Company snapshot

ETFs holding ATYR

Frequently asked questions